Ding Wei
No. 169, Changle West Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
The APC/C subunit APC7 promotes hepatocellular carcinoma progression by mediating ubiquitination and degradation of LATS1 to activate YAP/TAZ.
Journal: Biology direct
Published: December 30, 2025
Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2.
Journal: Signal transduction and targeted therapy
Published: July 15, 2025
hCCL19-expressing recombinant Newcastle disease virus boosts CAR T cell infiltration and efficacy in solid tumor.
Journal: Journal for immunotherapy of cancer
Published: July 02, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.
Journal: Signal transduction and targeted therapy
Published: November 01, 2024
Author Correction: An extra-erythrocyte role of haemoglobin body in chondrocyte hypoxia adaption.
Journal: Nature
Published: September 25, 2024
Integrated Analysis of the Anoikis-Related Signature Identifies Rac Family Small GTPase 3 as a Novel Tumor-Promoter Gene in Hepatocellular Carcinoma.
Journal: MedComm
Published: August 29, 2024
Correspondence to editorial on "UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL".
Journal: Clinical and molecular hepatology
Published: July 23, 2024
UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL.
Journal: Clinical and molecular hepatology
Published: April 07, 2024
Large HBV Surface Protein-Induced Unfolded Protein Response Dynamically Regulates p27 Degradation in Hepatocellular Carcinoma Progression.
Journal: International journal of molecular sciences
Published: July 20, 2023
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression.
Journal: Cancer communications (London, England)
Published: November 19, 2022
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial.
Journal: Signal transduction and targeted therapy
Published: November 11, 2022
Immunological and metabolic characteristics of the Omicron variants infection.
Journal: Signal transduction and targeted therapy
Published: May 26, 2022
Last Updated: 09/26/2026